Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No brainer at theses prices. Money to be made. Volume picking up, we will move up imo.
Got that right.
Yeah right, lol. Don't think so. Pretty even trading yesterday and a dump, may I say " planned dump" eod. Usual BS to try to make it look bad. Were good, it will bounce bad up in the morning I'm sure.
Buy them up... Great price. Go for it weedy, its in your ballpark. News comming, better hurry.
Annual comming, read last PR. Oh also,,,
". It could be a good time to accumulate KALY now under $0.04 before the positing of the company’s annual report or the removal of the OTC Markets flag."
Its comming off, very soon. Get in now or people will be chasing this, no doubt...
Hey, WB, did you know news is comming? Seems u post a lot more when its around that time. Funny how that works with you.
Ask them... Probually an ocean racer.
Well if you knew how to trade, you can make profits on any stock you invest in.
Boom, 6s, lets boom, boom, boom to 7s...lol
KALY's Upcoming Annual Report Likely To Trigger $0.01 PPS Run To $0.10
Source: InvestorsHub NewsWire
KALY’s Upcoming Annual Report Likely To Trigger $0.01 PPS Run To $0.10
?
New York, NY -- March 19, 2019 -- InvestorsHub NewsWire -- www.nextbigticker.com -- Kali-Extracts, Inc. (USOTC: KALY) acquired a patented cannabis extraction process in the fourth quarter of 2018. Shortly after the acquisition the company shot from sub-penny land to almost $0.04 on volume that put it in the top 20 most actively traded stocks on the OTC Market. The PPS retraced back to $0.01 and has been holding that price with a healthy trading volume. In the meantime, the company has published research reports on cannabis pharmaceutical developments and testing in addition to announcing its first sales of cannabis extracts for wellness products. KALY is providing CBD extracts for over $1 million worth of CBD infused water produced by Puration, Inc. (USOTC: PURA), and KALY has also introduced its own CBD infused gum. When the annual report is published in April, the first sales will be officially on the books and likely catapult the KALY PPS up to the $0.10 range were it justifiably should be. Between now and the filing of the annual report, the KALY PPS stands to return to its previous $0.04 high on anticipated news regarding its cannabis pharmaceutical developments and wellness product sales. Following the acquisition of the patented cannabis extraction process late last year and the corresponding jump in price and trading volume, the OTC Markets flagged the company in response to the jump in activity. The company has responded by updating all its OTC Markets required reports. Management is likely to mitigate the OTC Market’s concerns sooner or later and see the flag removed which will likely be yet another impetus fueling a KALY PPS run. It could be a good time to accumulate KALY now under $0.04 before the positing of the company’s annual report or the removal of the OTC Markets flag.
Management engaged Goldman Small Cap Research to conduct analyst coverage of the company and file an initial analyst report: KALY Research Report
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Source: www.nextbigticker.com
They are going to try to take NOUV down a noch today. If the MMs succeed, get in at 4s, that's a HUGE buy in my opinion. I will be looking too.
Do you have any idea how complex testing is for a medical use in helping for a chronic disease? Testing over and over again and again. Then approval from FDA. This will take quite awhile, but if it benefits COPD in anyway, this will be patent then huge profits come. It will be awhile but as long as they see something that may help in anyway what so ever, this will be huge down the road. Patients and understanding the process to getting there as an investment is long term with this, but will make investors rich imo.
No, lack of patients.. New businesses take time, doesn't take a geinus to understand how startups takes time. The products are created and being find tuned then production, distribution starts after marketing, then sales. Do you really think this can all be put together in a year? Not likely. The saying goes, do it right, or don't do it at all.... There's no sign of them not doing what their goals are. They are moving forward, if you understand anything about business, just because " you" think things should move faster, sometimes they don't. Its called PDCA, plan, do, check, act. Processes in business, sometimes over and over again and again till they get it right. If your invested in a startup and u want in low pps, now's the time, if you can't be patient purchase a higher costing stock, with a company that's been established for 5 years, then you may make 3 or 4 dollars on your dollar if you lucky in a few months. This is a penny stock, a he'll of a lot diffrent, startup which is going to take time to establish itself, eighter you have the patients or not, if not then sell and take off. Instead of doubting everything they do, or try to advance in to me " their goal" not yours or mine. Gltua. Just my opinion take it or leave it.
Our partners in USCH... Phase 2 comming.
KALY Initiates Phase Two Cannabis Extract COPD Treatment Study
Source: InvestorsHub NewsWire
Dallas, TX – March 18, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and the principal of Biomedical Science Research Group (BSRG), and KALY CEO Frederick Ferri met last week to coordinate a phase two study of a pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process. A report on the first primate study from Professor Jeffry Osbourn is coming soon. The primate study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies on COPD patients. The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The company has made recent advances in partnership with Puration, Inc. (USOTC: PURA) (“PURA”) developing a CBD extract for infusion into a beverage at a 25 mg concentration. The first target beverage for the 25 mg CBD concentrate beverage is a private labeled health water for Generex Biotechnology (OTCBB: GNBT).
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Interesting, ain't it WB... Thanks ZZ
Hint: does COPD ring a bell?
Find it yourself, I'm busy currently. Have fun.
Right, lol I found it and labs for testing extractions and potency.
Lol, find it yourself. There is a team and this board does not babysit. Do your own DD like everyone else.
Tomorrow will be interesting, news on the dividend with USMJ and PURA.
Wtf is this? Lol its the latest attorney letter, dates aren't different, you posted it twice. Lol give it up they are current. Proof is in the pudding..Lmfao.
Prove it.
Nouv is a spinoff, lol PURA sold NOUV. Pura price will go up imo, if people want extra shares. Price will go up or won't change at all for the divie. Get real.
Lol, really, my goodness. They are current...Lmfao, people are blind.
Shit, your going for CEO?
Just remember, if Texas takes their time doing shit, we have been based in Canada and now NY.. Keep everything in mind, keep tabs of the other plays involved with nouv, not just PURA and Kaly, there's quite a few.
MM manipulating is my thought, if you notice 5,6,5,6, They are accumulating shares for something big comming down the line. Seem they won't let it move out of this rut for now. They won't let it go below 5 and or above 6. This tells me there's a reason for this, I would think positive, cause if the play wasn't worth it they would let it drop. Whatever happens I say we go high the next time they lether rip. Glty
Don't read into it as much. Only read news Not this freaking board. Lol I get frustrated too, but when I do, I will stay away for bits at a time. I check for news and may pop in to see what people are saying, I don't stay on the boards, I find something to do and pop in when I want to see what's going on. I don't listen to the BS plastered on here eighter, got a mind of my own, don't need others thinking for me.
Don't know what's going on with that, last PR on pura was about the dividend update with nouv PURA, USMJ and objet. There's things happening in the company but, PRs are veg, and comming about slowly. I'm good with their progress being a young startup. It will no doubt all come about in due time. Patients is a must being multiple companies under the same CEO, wish he would get some help to move things more quickly though.
I like where this is heading, and this will clear up a few, BS post around here. This should be a sticky... USCH, PURA, Kaly, NOUV.
https://www.purationinc.com/2018-year-end-upate
Don't think so, they said in a PR awhile back they were looking to avoid that. Looking into a different route. Don't think we will see it.
Texas is where one of there farms is at, and 100 acres worth, plus this is where Kaly will do their extracting. NOUV is based out of Canada where PURA originated and the spinoff occurred.
I'm a long term investor, time is fine. But I think things will move much faster sooner. Imo.
Towards is a big difference between will do. Goal towards 3 mill, they didn't say they would, plus a mill is not a bad start.
This is the first one up on Google...
The best one, they need to update on goings on in Canada also.
https://www.purationinc.com/cannabis-bev
JMC, question...Could you please varify where you seen Kaly owns 50% of NOUV. I see they are partners with PURA, Kaly, and NOUV, 30% each under USCH. Did see they own 50 of NOUV... Do you have or can you get the link to that one. In invested in both and never seen it. Thanks
Agree, just waiting like everyone else. Its going to be great when it comes together. Not budging.